Last reviewed · How we verify

NCT05546684

The Effect of Foot Bath on Postoperative Sleep Quality in Patients Undergoing Transurethral Resection

Status unknown NA Last updated 4 October 2023
What this trial tests

NA trial testing footbath in The Effect of Footbath in 82 participants. Status unknown.

Timeline
26 September 2022
Primary endpoint
26 December 2022
25 December 2023

Quick facts

Lead sponsorKırklareli University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment82
Start date26 September 2022
Primary completion26 December 2022
Estimated completion25 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kırklareli University

Who can join

18 and older, any sex, with The Effect of Footbath. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Of the patients who meet the inclusion criteria, 82 will be determined prospectively. Randomization will be determined by means of a computer program called Research randomiser, provided that the number of patients in the experimental and control groups is equal (41:41), regardless of the characteristics of the patients such as age and gender. The group to which foot bath will be applied will be the experimental group. Other patients will be included in the control group. Patients who do not meet the study criteria and do not agree to participate in the random selection will not be included in the study. Experimental group: Individuals who applied to the urology service for TURP or TURM will be informed about the study 1 day before the operation, and the questions in the patient introduction form will be asked to the patients who declared that they agreed to participate in the study in writing and verbally. RCSQ to determine preoperative sleep quality for patients on the morning of surgery and Patient Methods to be applied / Research protocol to identify confounding factors that may affect sleep (Fill in the appropriate section below). Eligibility assessment: Of the patients who meet the inclusion criteria, 82 will be determined prospectively. Providing randomization and separation for intervention: Randomization will be determined by means of a computer program called Research randomiser, provided that the number of patients in the experimental and control groups is equal (41:41), regardless of the characteristics of the patients, such as age and gender. The group to which foot bath will be applied will be the experimental group. Other patients will be included in the control group. Patients who do not meet the study criteria and do not agree to participate in the random selection will not be included in the study. Experimental group: Individuals who applied to the urology service for TURP or TURM will be informed about the study 1 day before the operation, and the questions in the patient introduction form will be asked to the patients who declared that they agreed to participate in the study in writing and verbally. On the morning of the surgery, the RCSQ will be applied to the patients to determine the preoperative sleep quality and the Patient follow-up form will be applied to determine the confounding factors that may affect sleep, and after the patient comes from the surgery and the sedation effects have passed, at 21:00 (to prevent the patient from doing any activity after the application and to rest after the foot bath). It was determined as 21:00-22:00 hours for the purpose.) socks, etc., if any, on both feet of the patient. clothes will be removed. In case of using antiembolic stockings, the patient's stockings will be rolled up to the ankle for footbath application (with the approval of the physician). The foot will be examined visually and with the hands and it will be determined that it does not show any signs of disease (pressure injury, discoloration, wound, etc.). The patient will be informed that the footbath device is disinfected before each use and that water-proof bags will be placed on the device to prevent the foot and water from coming into contact with the device in order to allow repeated use. The temperature of the water will be adjusted to 400C with an infrared temperature meter (Non-contact digital thermometer) and both feet will be placed inside the footbath device. The patient's feet will be kept in the footbath device for ten minutes. After the foot bath, the patient's feet will be completely dried with a towel and the existing socks and anti-embolic socks will be put on again (Meltem Nurse). On the morning of the first postoperative day, the patient will be asked the questions in the RCSQ and follow-up form, and the data collection process of the study will be terminated. Control group: After informing the individuals who applied to the urology service for TURP or TURM about the study, the researcher will receive their informed consent in written form. The information required for the study of the patients in the control group 1 day before the operation will be recorded in the Patient Information Form by the service nurse (Meltem Nurse / Gizem Nurse). On the morning of the surgery, the RCSQ will be applied to the patients to determine the preoperative sleep quality and the Patient follow-up form will be applied to determine the confounding factors that may affect sleep. In the morning of the first day after the surgery, the RCSQ will be applied to the patients to determine the sleep quality on the postoperative day 0 and the Patient follow-up form will be applied to determine other possible factors that may affect sleep, and the data collection process of the study will be terminated. No foot bath application will be in question for the patients in the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Kırklareli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05546684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing